How is the regulatory landscape shaping drug development?

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Robert Albarano and Kristina Capiak from Arthur D Little, who have experience maximising commercial success of drug discovery portfolios and securing FDA designations. Bruno spoke to Robert and Kristina about the challenges of the regulatory landscape, the global implications of faster FDA approvals, and whether personalised medicines are set to become a key area for investment. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

You can listen to How is the regulatory landscape shaping drug development? online on Radio and Podcast. Open the player on this page to stream the available audio.

How is the regulatory landscape shaping drug development? is an episode from Drug Discovery World - Pharma, Drug Development, Therapeutics & Medicine by Drug Discovery World.

This episode is 22:33 long.

This episode was published on Apr 9, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Drug Discovery World - Pharma, Drug Development, Therapeutics & Medicine when more episodes are available from the podcast feed.